The University of Pennsylvania has received a three-year, $18 million grant from a major fundraising campaign to advance research on pancreatic cancer. The money will be used to test new compounds that can be used with radioisotopes to improve PET imaging of the cancer and to continue the search for weak spots in pancreatic cancer cells that can serve as drug targets.

Related Summaries